Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines. (2017)
Attributed to:
Realising the potential of a genetically engineered and uniquely cross protective vaccine for Bluetongue disease
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/jvi.01892-16
PubMed Identifier: 27795442
Publication URI: http://europepmc.org/abstract/MED/27795442
Type: Journal Article/Review
Volume: 91
Parent Publication: Journal of virology
Issue: 1
ISSN: 0022-538X